Stockhub

Shilpa Medicare Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 September 2022

  • curprev 01:3401:34, 23 September 2022 95.149.241.133 talk 972 bytes +972 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (APIs), intermediates, and formulations in India, the United States, Europe, and internationally. It's primary oncology and non-oncology APIs include capecitabine, gemcitabine hydrochloride, axitinib, erlotinib hydrochloride, and irinotecan hydrochloride, as well as ambroxol, tranexmic acid, an..."
Retrieved from "https://stockhub.co/research/Shilpa_Medicare_Limited"